Eligibility for Entry into First Line Metastatic Trials in Patients with Disease Recurrence within 12 Months of Adjuvant Chemotherapy for Early Stage Breast Cancer

Autor:	David Miles, M. Kadam, A. Ho, Andreas Makris, V. Bernhardt, Peter Ostler, S. Sutherland, T. Hussain, M. Ah-See, N. Shah, I.S. Bhattacharya
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty Adjuvant chemotherapy business.industry First line Disease medicine.disease Breast cancer Internal medicine medicine Radiology Nuclear Medicine and imaging In patient Stage (cooking) business
Zdroj:	Clinical Oncology. 27:e10
ISSN:	0936-6555
DOI:	10.1016/j.clon.2015.01.016
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ede3f00df31c5f6e44413282c8a83474 https://doi.org/10.1016/j.clon.2015.01.016 Zobrazit plný text záznamu Full Text from ScienceDirect